Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial
The Journal of Allergy and Clinical Immunology: In Practice · 2026-06 · 14 (6) · 1430-1437.e1
DOI: 10.1016/j.jaip.2026.02.019 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-06. Verfasst von Janine Mahoney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Speech Pathology, La Trobe University, Melbourne, Victoria, Australia; Speech Pathology Department, The Alfred, Melbourne, Victoria, Au…. Hauptthemen laut MEDLINE: Amitriptyline, Speech Therapy, Airway Obstruction, Laryngeal Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Speech Pathology, La Trobe University, Melbourne, Victoria, Australia; Speech Pathology Department, The Alfred, Melbourne, Victoria, Australia. Electronic address: J.Mahoney@alfred.org.au.
- Allergy, Asthma, and Clinical Immunology Service, The Alfred, Melbourne, Victoria, Australia; Department of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Speech Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia; College of Health, Medicine and Wellbeing, School of Medicine and Public Health, University of Newcastle, Newcastle, New South…
- Allergy, Asthma, and Clinical Immunology Service, The Alfred, Melbourne, Victoria, Australia; The Department of Respiratory Research @ Alfred, School of Translational Medicine, Monash University, Melbourne, Victoria, Au…
- Department of Speech Pathology, La Trobe University, Melbourne, Victoria, Australia.
Zitieren
APA
Mahoney, J., Hew, M., Vertigan, A., Lee, J., Denton, E., & Oates, J. (2026). Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice, 14(6), 1430-1437.e1. https://doi.org/10.1016/j.jaip.2026.02.019
Vancouver
Mahoney J, Hew M, Vertigan A, Lee J, Denton E, Oates J. Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(6):1430-1437.e1. doi:10.1016/j.jaip.2026.02.019
BibTeX
@article{Mahoney2026,
author = {Mahoney, Janine and Hew, Mark and Vertigan, Anne and Lee, Joy and Denton, Eve and Oates, Jennifer},
title = {Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {6},
pages = {1430--1437.e1},
doi = {10.1016/j.jaip.2026.02.019}
}
EUVIMED